期刊文献+

HOXB13 and other high penetrant genes for prostate cancer 被引量:1

HOXB13 and other high penetrant genes for prostate cancer
原文传递
导出
摘要 Cancer initiation and progression is the result of an accumulation of mutations inkey tumor suppressor genes, mismatch repair genes, or oncogenes, which impact cancer cell growth, death, and differentiation. Mutations occurring in cancer tissue are termed somatic; whereas, heritable mutatons that may be passed onto subsequent generations occur in germline DNA. It is these germline mutations that can lead to cancer family syndromeswhereby family members carrying a deleterious germline mutation have an increased susceptibility to certain cancer phenotypes. Common features of hereditary cancer syndromes include early age-of-onset, multiple affected generations, rare tumor types, and/or multiple primary malignancies. Cancer initiation and progression is the result of an accumulation of mutations inkey tumor suppressor genes, mismatch repair genes, or oncogenes, which impact cancer cell growth, death, and differentiation. Mutations occurring in cancer tissue are termed somatic; whereas, heritable mutatons that may be passed onto subsequent generations occur in germline DNA. It is these germline mutations that can lead to cancer family syndromeswhereby family members carrying a deleterious germline mutation have an increased susceptibility to certain cancer phenotypes. Common features of hereditary cancer syndromes include early age-of-onset, multiple affected generations, rare tumor types, and/or multiple primary malignancies.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2016年第4期530-532,共3页 亚洲男性学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献110

  • 1FerlayJ, Shin HR, Bray F, Forman D, Mathers C etal. Estimatesofworldwide burden of cancer in 2008: GLOBOCAN 2008. IntJ Cancer 2010; 127: 2893-917.
  • 2Lee J, Demissie K, Lu SE, Rhoads GG. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 2007; 14: 78-85.
  • 3Jemal A, Bray F, Center MM, Ferlay J, Ward E etal. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
  • 4Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367-71.
  • 5Eeles RA. Genetic predisposition to prostate cancer. Prostate Cancer Prostatic Dis 1999; 2: 9-15.
  • 6Edwards SM, Eeles RA. Unravelling the genetics of prostate cancer. Am J Med GenetC Semin Med Genet 2004; 129C: 65-73.
  • 7Lichtenstein P, Holm NV, Verkasalo PK, lIiadou A, Kaprio J et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
  • 8Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-9.
  • 9AI Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison Jet al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009; 41: 1058-60.
  • 10Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652-8.

共引文献10

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部